Connect with us

Technology

CAS and Cleveland Clinic collaborate to accelerate research through advanced AI and quantum computing

Published

on

COLUMBUS, Ohio, April 7, 2025 /PRNewswire/ — CAS, a division of the American Chemical Society specializing in scientific content and knowledge management, and Cleveland Clinic, an academic health system with a global footprint, announced plans for a strategic collaboration that will unite the organizations’ unique expertise, technology, and data capabilities to fuel clinical research.

During the Cleveland Discovery & Innovation Forum, an event highlighting cutting-edge healthcare and life sciences research, the two global organizations announced that their collaboration’s first strategic focus area will be aiming to advance research on health, wellness, and healthy aging. Initial projects the organizations are discussing will focus on drug discovery for brain health, a priority underscored by the relative lack of effective, disease-modifying treatments for Alzheimer’s due to the complex nature of the disease.

“This unique collaboration leverages Cleveland Clinic’s expertise in biomedical research and clinical care with CAS leadership in scientific data and technology,” said Lara Jehi, M.D., Cleveland Clinic Chief Research Information Officer. “By combining our strengths, we aim to create high-quality medical data, validate scientific models, and integrate research to ultimately enhance patient care and chronic disease management.”

The effort will harness the CAS Content Collection™, the world’s most comprehensive curated scientific information resource, with advanced technologies, including new AI models and quantum computing. As part of its partnership with IBM, Cleveland Clinic houses an IBM Quantum System One, the world’s first quantum computer fully dedicated to healthcare research.

The collaborators plan to build and train disease-specific models, starting with Alzheimer’s, focused on advancing preventative and predictive strategies, and potentially translating them to other chronic diseases in the future.

“CAS is delighted to partner with Cleveland Clinic, an institution renowned for its exceptional research and innovation,” said Manuel Guzman, CAS President. “Recognizing it takes 17 years for a scientific discovery in a lab to become an approved test or therapy, we are confident that together, we can close that gap. Led by our shared goal of improving people’s lives through scientific innovation, we will combine high-quality content, subject expertise, and advanced technologies to discover new paths to healthy aging and drive positive social and economic impacts.”

The initiative will benefit from the Cleveland Innovation District, which brings the State of Ohio and JobsOhio together with Cleveland’s healthcare and higher education institutions to create jobs, accelerate research, and educate the future workforce.

About CAS

CAS connects the world’s scientific knowledge to accelerate breakthroughs that improve lives. We empower global innovators to efficiently navigate today’s complex data landscape and make confident decisions in each phase of the innovation journey. As a specialist in scientific knowledge management, our team builds the largest authoritative collection of human-curated scientific data in the world and provides essential information solutions, services, and expertise. Scientists, patent professionals, and business leaders across industries rely on CAS to help them uncover opportunities, mitigate risks, and unlock shared knowledge so they can get from inspiration to innovation faster. CAS is a division of the American Chemical Society.

About Cleveland Clinic  

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 81,000 employees worldwide are more than 5,743 salaried physicians and researchers, and 20,160 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,690-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 276 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2023, there were 13.7 million outpatient encounters, 323,000 hospital admissions and observations, and 301,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 132 countries.

Photo – https://mma.prnewswire.com/media/2658551/CAS_Cleveland_Clinic.jpg
Logo – https://mma.prnewswire.com/media/1729161/CAS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/cas-and-cleveland-clinic-collaborate-to-accelerate-research-through-advanced-ai-and-quantum-computing-302421255.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

LOWE’S INVITES BAY AREA RESIDENTS TO “TRY ON” THEIR KITCHEN WITH LOWE’S STYLE STUDIO™

Published

on

By

Designed exclusively for Apple Vision Pro, Lowe’s Style Studio™ empowers customers to visualize and experience a kitchen refresh in minutes at five Bay Area stores starting April 26

CHARLOTTE, N.C., April 25, 2025 /PRNewswire/ — Beginning Saturday, April 26, Lowe’s stores in northern California will offer free appointments for Lowe’s Style Studio™, an immersive 3D experience that lets customers design and “try on” their dream kitchen using Apple Vision Pro, changing the colors, styles, and features around them in real time. Lowe’s Style Studio™ combines spatial computing with home improvement, giving customers the ultimate confidence of experiencing their dream kitchen—or a smaller project like a new sink or wall color —before actually renovating it.

“We try on clothes, sample paint colors, and test drive cars to help us decide before we buy,” said Chandhu Nair, Lowe’s SVP of Data, AI and Innovation. “Customers deserve that same confidence when it comes to home renovation. With Lowe’s Style Studio, consumers don’t have to guess what their new kitchen could look like—they can step into it and experience their style choices together as if they are actually there. This is the future of retail—personal, immersive, and powered by technology.”

Lowe’s shoppers can focus on a single aspect of the kitchen—like a new cabinet color—or reimagine the entire room using Lowe’s Style Studio™ for Apple Vision Pro. Within the experience they can view full-sized countertops, backsplashes, and appliances within a kitchen, all for free. This is particularly helpful for products like countertops, where a full scale rendering allows customers to see additional variation and veining. Whether it’s a major overhaul or a small refresh, Lowe’s Style Studio™ makes it easy to explore design possibilities before spending a dime.

The pressure to get kitchen remodels right impacts DIYers and the Pros that support them. Interior designers, real estate agents, and installers have used Lowe’s Style Studio™ to help clients feel more comfortable with their design selections. By turning ideas into immersive, shared experiences, the tool brings everyone to the table with clarity and confidence—and with Lowe’s lowest price guarantee, customers can feel good about their choices from every angle. Spatial computing seamlessly blends digital content into the physical space, enabling users to interact in stunning resolution, using intuitive input controlled by a user’s eyes and hands.

Customers are encouraged to bring family members or home professionals to their session, where they can follow along on an iPad that mirrors the Apple Vision Pro experience. Customers can then digitally save and share their selected styles at the end of the session. These can also be saved to the customer’s Lowes.com account for future reference at home.

Sessions are free with no purchase commitments and available by appointment or walk-in (appointments are preferred). Appointments can be made at Lowes.com for the following California stores:

Concord, 1935 Arnold Industrial Way, ConcordEast San Jose, 775 Ridder Park Dr., San JoseDublin, 3750 Dublin Blvd., DublinSouth San Jose, 5550 Cottle Rd., San JoseSunnyvale, 811 East Arques Ave., Sunnyvale

About Lowe’s
Lowe’s Companies, Inc. (NYSE: LOW) is a FORTUNE® 50 home improvement company serving approximately 16 million customer transactions a week in the United States. With total fiscal year 2024 sales of more than $83 billion, Lowe’s operates over 1,700 home improvement stores and employs approximately 300,000 associates. Based in Mooresville, N.C., Lowe’s supports the communities it serves through programs focused on creating safe, affordable housing, improving community spaces, helping to develop the next generation of skilled trade experts and providing disaster relief to communities in need. For more information, visit Lowes.com.

Media Contact
Caitlin Byrnes
Lowe’s Companies, Inc.
caitlin.byrnes@lowes.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lowes-invites-bay-area-residents-to-try-on-their-kitchen-with-lowes-style-studio-302438748.html

SOURCE Lowe’s Companies, Inc.

Continue Reading

Technology

Zepp Health Corporation Files 2024 Annual Report on Form 20-F

Published

on

By

MILPITAS, Calif., April 25, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp Health” or the “Company”) (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has filed its annual report on Form 20-F for the full year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the “SEC”).

The annual report can be accessed on the Company’s investor relations website at http://ir.zepp.com and on the SEC’s website at www.sec.gov. The Company will provide hardcopies of the annual report, free of charge, to its shareholders and ADS holders upon request. Requests should be submitted to ir@zepp.com.

About Zepp Health Corporation (NYSE: ZEPP)

Zepp Health Corporation (NYSE: ZEPP) is a global smart wearable and health technology leader, empowering users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its leading consumer brands, Amazfit, Zepp Clarity and Zepp Aura. Powered by its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors and data algorithms, Zepp delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. To date, Zepp has shipped over 200 million units, and its products are available in more than 90 countries and regions. Founded in 2013 as Huami Corp., the Company changed its name to Zepp Health Corporation in February 2021 to emphasize its health focus with a name that resonates across languages and cultures globally. Zepp has team members and offices across globe, especially in Europe and USA regions.

For investor and media inquiries, please contact:

In China:
Zepp Health Corporation
Grace Yujia Zhang
Email: ir@zepp.com 

Piacente Financial Communications
Tel: +86-10-6508-0677
Email: zepp@tpg-ir.com 

 

View original content:https://www.prnewswire.com/news-releases/zepp-health-corporation-files-2024-annual-report-on-form-20-f-302438423.html

SOURCE Zepp Health Corp.

Continue Reading

Technology

Symphony Robotics Welcomes Neurosurgery Leader Dr. Neil A. Martin as Chief Medical Officer to Revolutionize Glioblastoma Treatment with First-Ever MRI-Steerable Micro-Robotics

Published

on

By

MIAMI, April 25, 2025 /PRNewswire/ — Symphony Robotics, a pioneer in advanced neurosurgical micro-robotics, today announced the appointment of renowned neurosurgeon Dr. Neil A. Martin as its Chief Medical Officer (CMO). In this pivotal role, Dr. Martin will lead the advancement of the company’s groundbreaking, engine-free, nonlinear, flexible micro-robotic system, poised to transform the treatment landscape for Glioblastoma Multiforme (GBM).

Symphony Robotics, a pioneer in advanced neurosurgical micro-robotics, appoints renowned neurosurgeon as CMO.

“Glioblastoma remains the most treatment-resistant and lethal primary brain tumor, with a median survival of only 14-16 months following maximal safe resection plus adjuvant chemoradiotherapy, and a five-year survival rate below 7%,” stated Dr. Martin. “Despite significant advances in molecular characterization and targeted therapeutics, meaningful improvements in clinical outcomes have remained elusive.”

Early preclinical studies using anatomically accurate GBM models under real-time MRI guidance have shown that Symphony Robotics’ platform achieves significant improvements in maneuverability, resulting in up to 3 times the volumetric coverage when compared with existing technologies, with millimeter-level precision, crucial for protecting critical healthy brain tissue while maximizing tumor removal.

Dr. Martin continued, “Symphony Robotics is positioned to transform the treatment paradigm by substantially extending the capabilities of Laser Interstitial Thermal Therapy (LITT) in GBM—potentially tripling the ablation volume achievable through its steerability after single-site minimally invasive insertion. Our initial objective is to significantly enhance the efficacy of LITT through precise, nonlinear navigation to previously unreachable tumor margins, even in large and irregular tumors. We are implementing an aggressive translational research pipeline for developing applications to accompany and synergize with thermal ablation, including targeted drug and immunotherapy delivery systems for precision neuro-oncology.”

“Symphony Robotics is built on a foundation of rigorous research and a robust intellectual property portfolio, supported by grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF), and exclusively licensed from Case Western Reserve University,” said Mordechai (Moty) Avisar, Founder and CEO of Symphony Robotics. “Welcoming Dr. Martin—a visionary leader in neurosurgery—to our team marks a pivotal milestone that will accelerate our mission to revolutionize GBM treatment. By harnessing the power of artificial intelligence, our platform is poised to optimize therapy and deliver this life-changing technology to patients worldwide.”

The company is currently establishing collaborations with leading neurosurgical centers to initiate beta site testing later this year, ensuring thorough clinical assessment in diverse patient populations and anatomical scenarios.

CONTACT: info@symphonyrobotics.health
LinkedIn: https://www.linkedin.com/company/symphonyrobotics/

Symphony Robotics is developing advanced medical technology focused on transforming neurosurgical precision through its engine-free, nonlinear, flexible, micro-robotic platform, leveraging AI to optimize GBM treatment. Recognizing the limitations of current techniques in treating complex intracranial pathologies, particularly aggressive cancers like GBM and medically refractory epilepsy, the company aims to improve surgical outcomes by enabling more precise and extensive tumor ablation, minimizing damage to healthy brain tissue, and ultimately improving both patient survival and quality of life. The integration of real-time MRI guidance with advanced robotics and computational navigation algorithms allows their innovative platform to access and treat previously unreachable areas within the brain. Disclaimer: Symphony Robotics’ products are not approved by the Food and Drug Administration (FDA) and are not available for commercial distribution or clinical use.

View original content to download multimedia:https://www.prnewswire.com/news-releases/symphony-robotics-welcomes-neurosurgery-leader-dr-neil-a-martin-as-chief-medical-officer-to-revolutionize-glioblastoma-treatment-with-first-ever-mri-steerable-micro-robotics-302438762.html

SOURCE Symphony Robotics

Continue Reading

Trending